癌の免疫療法のためのAsp-Phe-Tyrトリペプチドの酵素触媒化されたポリメリゼーション反応に基づく戦略
Qiu-Ling Zhang1, Diwei Zheng1, Xue Dong2
1Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, P.R. China.
Journal of the American Chemical Society
|March 25, 2021
まとめ
この研究は,腫瘍の抗原を免疫細胞に伝達し,メラノーマの成長と再発を効果的に抑制することによって,がん免疫療法を強化するために,Asp-Phe-Tyr (DFY) トリペプチドを用いた新しい腫瘍タンパク質工学システムを導入しています.
科学分野:
- 生物化学
- 免疫学
- 化学生物学
背景:
- 免疫療法はがん治療において有望であるが,全身抗原呈現抑制によって制限されている.
- 腫瘍抗原を免疫細胞にターゲットに投与することは 効果的ながん免疫療法に不可欠です
研究 の 目的:
- 癌の免疫療法を強化する 腫瘍タンパク質エンジニアリングシステムを開発する
- Asp-Phe-Tyr (DFY) トリペプチドを標的型抗原の採取および配送に使用する.
主な方法:
- DFYトリペプチドに基づいたシステムを構築し,免疫遺伝的腫瘍タンパク質を収集し,提供しました.
- メラノーマ細胞におけるDFY蓄積のためのチロシナーゼ誘導ポリメリゼーションを使用した.
- 腫瘍タンパク質は,ミカエル添加によってキノンの豊富な中間物質に結合し,タンパク質を運ぶマイクロファイバーを形成する.
- ネズミのメラノーマモデルでのシステムの有効性を評価した.
主要な成果:
- DFYシステムは選択的にメラノーマ細胞に蓄積され,腫瘍タンパク質を運ぶマイクロファイバーを形成した.
- これらの微細繊維は 抗原を提示する細胞に包まれていて 腫瘍の抗原特性を示しています
- このシステムは,抗原が欠乏したメラノーマ細胞に腫瘍抗原を成功裏に濃縮し,輸送しました.
- 皮膚経由でのDFY投与は,腫瘍の成長を抑制し,手術後の再発を vivoで抑制しました.
結論:
- DFYベースのシステムは 癌と戦うために 免疫系を調節する新しい戦略を提供します
- このアプローチは,抗原プレゼンテーションの制限を克服することによって,免疫療法を強化します.
- この研究は,がん治療における化学生物学とポリメリゼーション反応の可能性を強調しています.
さらに関連する動画
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
12.1K
10:33Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
Published on: April 25, 2025
703
関連する概念動画
Tumor Immunotherapy
820
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
820
Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K
Cancer Vaccines
610
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
610
Combination Therapies and Personalized Medicine
5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
